Amantadine is a medication with dual uses, serving both as an antiviral agent and as a treatment for Parkinson's disease. In the antiviral context, amantadine is primarily employed to inhibit the replication of influenza A viruses. It works by blocking the M2 ion channel protein, preventing the release of viral RNA into host cells. This antiviral property has made amantadine a part of influenza prevention and treatment strategies. In neurology, amantadine finds application in the treatment of Parkinson's disease. Although the precise mechanism of its action in this context remains incompletely elucidated, it is thought to influence dopamine release and receptor sensitivity in the brain. This modulation is believed to alleviate certain symptoms associated with Parkinson's disease, including tremors and bradykinesia. Side effects of amantadine include nausea, dizziness, and insomnia. In the case of prolonged use, patients may develop resistance to its antiviral effects. However, its role in managing Parkinson's disease has established amantadine as a valuable component of the therapeutic arsenal for neurologists.